[1]张美娜,张 斌△.慢性牙周炎合并冠心病患者血清Vaspin、Apelin、Chemerin水平与牙周临床指数相关性探讨*[J].陕西医学杂志,2020,49(5):557-560,602.
 ZHANG Meina,ZHANG Bin..Correlation between serum Vaspin,Apelin,Chemerin levels and periodontal clinical index in patients with chronic periodontitis and coronary heart disease[J].,2020,49(5):557-560,602.
点击复制

慢性牙周炎合并冠心病患者血清Vaspin、Apelin、Chemerin水平与牙周临床指数相关性探讨*
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年5期
页码:
557-560,602
栏目:
临床研究
出版日期:
2020-05-05

文章信息/Info

Title:
Correlation between serum Vaspin,Apelin,Chemerin levels and periodontal clinical index in patients with chronic periodontitis and coronary heart disease
文章编号:
DOI:10.3969/j.issn.10007377.2020.05.012
作者:
张美娜张 斌
锦州医科大学附属第一医院口腔科(锦州121000)
Author(s):
ZHANG MeinaZHANG Bin.
Department of Stomatology,First Affiliated Hospital of Jinzhou Medical University(Jinzhou 121000)
关键词:
慢性牙周炎 冠心病 内脏脂肪特异性丝氨酸蛋白酶抑制剂 脂肪因子 脂肪因子趋化素 牙周临床指数
Keywords:
Chronic periodontitis Coronary heart disease Visceral fat-derived serine protease inhibitor Apelin Adipocytokine chemokine Periodontal clinical index
分类号:
R781.4
文献标志码:
A
摘要:
目的:探讨慢性牙周炎(CP)合并冠心病(CHD)患者血清内脏脂肪特异性丝氨酸蛋白酶抑制剂(Vaspin)、脂肪因子(Apelin)、脂肪因子趋化素(Chemerin)水平与牙周临床指数的关系。方法:选择慢性牙周炎患者160例为研究对象,其中CP合并CHD患者80例为试验组,单纯慢性周炎患者80例为对照组(NC组)。采用酶联免疫吸附法(ELISA)检测并记录所有研究对象血清中Vaspin、Apelin、Chemerin水平,检查测量所有研究对象牙周探诊深度(PD)、牙周附着水平(PAL)、菌斑指数(PI)、探诊出血指数(BI)、牙龈指数(GI),Pearson分析慢性牙周炎合并冠心病患者血清Vaspin、Apelin、Chemerin水平与PD、PAL、PI、BI、GI之间的相关性,Logistic回归分析CP患者发生CHD的危险因素。结果:试验组和NC组在性别、年龄上比较差异无统计学意义(P>0.05),试验组有吸烟史和高血压史的人数显著多于NC组(P<0.05); 与NC组比较,试验组Vaspin、Apelin水平较低,Chemerin水平较高(P<0.05); 与NC组比较,试验组PD、PAL、PI、BI、GI指数较高(P<0.05); 试验组患者血清Vaspin水平与PD、PAL、PI、BI、GI指数呈负相关(P<0.05); Apelin水平与PD、PAL、PI、BI、GI指数呈负相关(P<0.05); Chemerin水平与PD、PAL、PI、BI、GI指数呈正相关(P<0.05); 多因素Logistic回归分析显示年龄、高血压史、吸烟史、Chemerin高水平均为影响CP患者发生CHD的独立危险因素,Vaspin、Apelin高水平为独立保护因素(P<0.05)。结论:CP合并CHD患者血清Vaspin、Apelin水平较低、Chemerin水平较高,与患者牙周指数有关,均为CP患者发生CHD的影响因素。
Abstract:
Objective:To investigate the correlation between serum visceral fat-derived serine protease inhibitor(Vaspin),adipokines(Apelin)and adipocyte chemokine(Chemerin)levels and periodontal clinical index in patients with chronic periodontitis(CP)and coronary heart disease(CHD). Methods:160 patients with CP were selected as the research objects,of which 80 patients with CP and CHD were in the experimental group,and 80 patients with simple CP were in the control group(NC group). The levels of serum Vaspin,Apelin and Chemerin were detected by ELISA. The periodontal exploration depth(PD),periodontal attachment level(PAL),plaque index(PI),visiting bleeding index(BI),gingival index(GI)were measured. The correlation between serum Vaspin,Apelin,Chemerin levels and PD,PAL,PI,BI,GI in patients with periodontitis was analyzed by Pearson analysis,and Logistic regression was used to analyze the risk factors of CHD in patients with CP. Results:There was no significant difference in gender and age between the experimental group and the NC group(P>0.05). The numbers of patients with smoking history and hypertension history in the experimental group were significantly higher than those in NC group(P<0.05). Compared with the NC group,the levels of Vaspin and Apelin in the experimental group were lower and the level of Chemerin was higher(P<0.05). Compared with the NC group,the indexes of PD,PAL,PI,BI and GI in the experimental group were higher(P<0.05). The serum Vaspin level was negatively correlated with the indexes of PD,PAL,PI,BI and GI in the experimental group(P<0.05). Apelin level was negatively correlated with the indexes of PD,PAL,PI,BI and GI(P<0.05). Chemerin level was positively correlated with the indexes of PD,PAL,PI,BI and GI(P<0.05). Multivariate Logistic regression analysis showed that age,hypertension history,smoking history and high level of Chemerin were independent risk factors for CHD in patients with CP,and high levels of Vaspin and Apelin were independent protective factors(P<0.05). Conclusion:The lower levels of serum Vaspin,Apelin and the higher level of serum Chemerin in patients with CP and CHD are related to periodontal index,and they are the influencing factors for the occurrence of CHD in patients with CP.

参考文献/References:

[1] 孟红军,王守儒. 养阴清火方治疗慢性牙周炎疗效及对患者TNF-α、IL-1β、IL-6影响的研究[J]. 陕西中医,2018,39(12):1731-1734.
[2] 刘海涛,牛文燕. 慢性牙周炎患者基础治疗前后血清及龈沟液脂联素水平的变化及临床意义[J]. 陕西医学杂志,2018,47(2):225-227.
[3] Aoyama N,Kobayashi N,Hanatani T,et al. Periodontal condition in Japanese coronary heart disease patients:a comparison between coronary and non-coronary heart diseases[J].J Periodontal Res,2019,54(3):259-265.
[4] Montazerifar F,Bakhshipour AR,Karajibani M,et al. Serum omentin-1,vaspin,and apelin levels and central obesity in patients with nonalcoholic fatty liver disease[J]. J Res Med Sci,2017,30(22):70-89.
[5] Wysocka MB,Pietraszek-Gremplewicz K,Nowak D. The role of apelin in cardiovascular diseases,obesity and cancer[J]. Front Physiol,2018,9(1):557-603.
[6] 张国明,何丽芸,阿扎玛提?阿扎提,等. 动脉粥样硬化斑块与龈下菌斑中牙周致病菌的关系研究[J]. 实用心脑肺血管病杂志,2017,25(7):13-17.
[7] Ramachandra SS,Gupta VV,Mehta DS,et al. Differential diagnosis between chronic versus aggressive periodontitis and staging of aggressive periodontitis:a cross-sectional study[J]. Contemp Clin Dent,2017,8(4):594-603.
[8] 颜红兵,马长生,霍 勇. 临床冠心病诊断与治疗指南[M]. 北京:人民卫生出版社,2010:23-26.
[9] 王建旗,史旭波. 炎症预测和预防动脉粥样硬化性心血管事件的研究进展[J].心血管病学进展,2018,39(5):687-690.
[10] Ziebolz D,Jahn C,Pegel J,et al. Periodontal bacteria DNA findings in human cardiac tissue - is there a link of periodontitis to heart valve disease[J]. Int J Cardiol,2018,251(1):74-79.
[11] 程景明.某区老年群体牙周炎与冠心病同患病的流行病学调查[J].河南医学高等专科学校学报,2018,30(1):40-41.
[12] 刘钰宇.冠心病与慢性牙周炎相关性的分析[J].现代口腔医学杂志,2016,30(3):169-172.
[13] 李 爽,易根云,李志强,等.牙周炎与冠心病之间联系机制的研究进展[J].口腔医学研究,2017,33(4):455-458.
[14] Stancik M,Sagova I,Kantorova E,et al. The role of vaspin as a predictor of coronary angiography result in SCAD(stable coronary artery disease)patients[J]. BMC Cardiovasc Disord,2017,17(1):117-141.
[15] 罗庆慧,苏国海. 冠心病患者血清Vaspin与脂联素的水平变化及意义[J].山东医药,2018,58(13):69-71.
[16] Tran K,Murza A,Sainsily X,et al. A systematic exploration of macrocyclization in apelin-13:impact on binding,signaling,stability,and cardiovascular effects[J]. J Med Chem,2018,61(6):2266-2277.
[17] 曾文平,熊艳华,王丽娟,等. 冠心病患者血清ox-LDL、Apelin水平变化及其临床意义[J]. 现代实用医学,2018,30(3):315-316.
[18] Wang X,Liu J,Wang D,et al. Expression and correlation of Chemerin and FABP4 in peripheral blood of gestational diabetes mellitus patients[J]. Exp Ther Med,2020,19(1):710-716.
[19] Zylla S,Dorr M,Volzke H,et al. Association of circulating chemerin with subclinical parameters of atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2018,38(7):1656-1664.
[20] 闫晓红,刘晓红,张贞美,等. 不同冠状动脉病变支数冠心病患者血清Chemerin水平变化及其意义[J]. 山东医药,2019,59(7):63-65.
[21] Ozcan E,Saygun NI,Serdar MA,et al. Evaluation of the salivary levels of visfatin,chemerin,and progranulin in periodontal inflammation[J]. Clin Oral Investig,2015,19(4):921-928.
[22] 肖 燕,刘 冰,朱娟芳,等.牙周治疗对慢性牙周炎伴冠心病患者血清CRP、IL-8和TNF-α水平的影响[J]. 河南医学研究,2017,26(20):3662-3664.

相似文献/References:

[1]杨 铮,黄 萍△,杨 阳,等.西安地区中老年人血清尿酸检测的临床价值研究*[J].陕西医学杂志,2019,(7):951.
 YANG Zheng,HUANG Ping,YANG Yang,et al.Clinical value of serum uric acid in middle-aged and elderly patients in Xi’an[J].,2019,(5):951.
[2]董 昕,杨朋康△.单硝酸异山梨酯联合维拉帕米对冠心病稳定型心绞痛患者血脂水平及血清同型半胱氨酸、高敏C反应蛋白的影响*[J].陕西医学杂志,2020,49(4):485.
 DONG Xin,YANG Pengkang..Effect of isosorbide mononitrate combined with verapamil on blood lipids levels and serum HCY and hs-CRP in patients with stable angina pectoris[J].,2020,49(5):485.
[3]陈伟国,朱萧玲,常 盼,等.2型糖尿病患者冠状动脉狭窄程度危险因素分析*[J].陕西医学杂志,2020,49(6):672.[doi:DOI:10.3969/j.issn.10007377.2020.06.008]
 CHEN Weiguo,ZHU Xiaoling,CHANG Pan,et al.Risk factors of coronary stenosis in patients with type 2 diabetes mellitus[J].,2020,49(5):672.[doi:DOI:10.3969/j.issn.10007377.2020.06.008]
[4]李 垚,陈万林,杨 平,等.亚甲基四氢叶酸还原酶基因C677T多态性与冠心病患者冠状动脉病变及叶酸水平相关性研究[J].陕西医学杂志,2021,50(1):22.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.005]
 LI Yao,CHEN Wanlin,YANG Ping,et al.Correlation of methylenetetrahydrofolate reductase gene C677T polymorphism with coronary artery disease and folic acid level in patients with coronary heart disease[J].,2021,50(5):22.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.005]
[5]尹小花,徐 荣,郭 鑫,等.冠状动脉CT血管造影预测冠脉斑块患者发生左心室重构临床价值研究[J].陕西医学杂志,2021,50(2):192.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.017]
 YIN Xiaohua,XU Rong,GUO Xin,et al.Coronary CTA in prediction of left ventricular remodel in patients with coronary plaque[J].,2021,50(5):192.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.017]
[6]罗 薇,韩 勇,王莉萍,等.西地兰联合贝那普利对老年冠心病心力衰竭患者心功能及金属蛋白酶组织抑制因子-4、游离脂肪酸表达的影响[J].陕西医学杂志,2021,50(2):216.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.023]
 LUO Wei,HAN Yong,WANG Liping,et al.Effects of cedilan and benazepril on cardiac function and expression of TIMP-4 and FFA in elderly patients with coronary heart disease and heart failure[J].,2021,50(5):216.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.023]
[7]姜 育,张 洁,陈 群,等.心外膜脂肪组织厚度对2型糖尿病合并冠心病患者血管事件发生的预测价值[J].陕西医学杂志,2021,50(5):542.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.007]
 JIANG Yu,ZHANG Jie,CHEN Qun,et al.Value of epicardial adipose tissue thickness in predicting the occurrence of vascular events in patients with type 2 diabetes and coronary heart disease[J].,2021,50(5):542.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.007]
[8]刘博强,张伟宁,忽海洋.miRNA-26a-5p靶向调控蛋白酪氨酸磷酸酶基因对冠心病模型大鼠主动脉内皮细胞炎症损伤的影响[J].陕西医学杂志,2021,50(11):1349.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.007]
 LIU Boqiang,ZHANG Weining,HU Haiyang.Effect of targeted regulation of protein tyrosine phosphatase gene by miRNA-26a-5p on inflammatory injury of aortic endothelial cells in rats with coronary heart disease[J].,2021,50(5):1349.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.007]
[9]王 晶,刘易婷,刘 哲.替米沙坦联合瑞舒伐他汀治疗糖尿病合并冠心病对患者外周胰岛素抵抗、糖化血红蛋白、脂蛋白和心肌缺血的影响[J].陕西医学杂志,2022,51(5):595.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.019]
 WANG Jing,LIU Yiting,LIU Zhe.Effects of telmisartan combined with rosuvastatin on peripheral insulin resistance,glycosylated hemoglobin,lipoproteins and myocardial ischemia in diabetic patients with coronary heart disease[J].,2022,51(5):595.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.019]
[10]李皓洋,王 佳,王美雪,等.低血钾在DeBakeyⅠ型主动脉夹层和其他类型主动脉夹层患者中的差异及临床意义[J].陕西医学杂志,2023,52(1):45.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.010]

备注/Memo

备注/Memo:
*辽宁省科学技术计划项目(2017225057)
更新日期/Last Update: 2020-07-28